Early-onset colorectal cancer is associated with markedly increased tissue stiffness and fibrosis, suggesting a distinct ...

In this global network study, researchers examined vitamin B12 levels as a possible biomarker for outcomes in colon cancer.

Colon cancer is relatively common in the U.S. The American Cancer Society (ACS) estimates that it's the third-most common cancer (excluding skin) and more than 106,000 people will be diagnosed with ...

In a groundbreaking development, researchers at KAIST (Korea Advanced Institute of Science and Technology) unveiled a new technology that treats colon cancer without killing cancer cells. Instead, the ...

Professor Kwang-Hyun Cho’s research team has recently been highlighted for their work on developing an original technology for cancer reversal treatment that does not kill cancer cells but only ...

Colon cancer has a way of sneaking up on people. That’s why it’s often called a “silent killer.” ...

< Figure 1. Technology for creating a digital twin of a gene network from single-cell transcriptome data of a normal cell differentiation trajectory. Professor Kwang-Hyun Cho's research team developed ...